RFT1 activators represent a specialized class of compounds designed to target and enhance the activity of the RFT1 protein. RFT1, or Resistance to Fragmentation 1, is a protein encoded by the RFT1 gene and is primarily associated with its role in N-glycosylation, a crucial post-translational modification process in cells. N-glycosylation involves the attachment of complex sugar molecules to proteins, which plays pivotal roles in protein folding, stability, and cellular trafficking. RFT1 is specifically involved in the translocation of sugar precursors across the endoplasmic reticulum (ER) membrane, an essential step in N-glycosylation. Activators of RFT1 are designed to upregulate its biological activity or stability, potentially influencing its role in mediating sugar precursor transport across the ER membrane, thereby affecting the glycosylation of proteins. These activators may comprise a diverse range of chemical structures, from small organic molecules to larger biomolecules, each selectively interacting with RFT1 to modulate its function within the cell.
Research into RFT1 activators typically involves a multidisciplinary approach, combining techniques from molecular biology, biochemistry, and cell biology to elucidate their effects on RFT1 function and their impact on cellular processes. Scientists investigate the interaction between RFT1 and its activators by examining changes in protein stability, substrate transport kinetics, and its role in N-glycosylation. Commonly used techniques include transport assays to measure sugar precursor translocation, co-immunoprecipitation to identify protein-protein interactions, and western blotting to assess protein levels. Additionally, cellular assays that monitor glycosylation patterns, protein folding, or ER-related processes can provide insights into the functional consequences of RFT1 activation. Through these investigations, researchers aim to uncover the precise roles of RFT1 in N-glycosylation, how its activity is regulated, and how modulation by specific activators can impact the glycosylation of proteins, contributing to a deeper understanding of the essential molecular mechanisms governing protein biology within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-(+)-Trehalose Anhydrous | 99-20-7 | sc-294151 sc-294151A sc-294151B | 1 g 25 g 100 g | $29.00 $164.00 $255.00 | 2 | |
A disaccharide that can stabilize proteins, potentially influencing cellular stress pathways and gene expression related to protein folding. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $75.00 $163.00 $622.00 $4906.00 $32140.00 | 43 | |
A chemical chaperone that may reduce ER stress, potentially upregulating genes involved in protein folding, including RFT1. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $197.00 $764.00 | ||
Involved in the biosynthesis of glycosylated proteins, which might affect the expression of genes related to N-linked glycosylation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
An N-linked glycosylation inhibitor that induces ER stress, potentially altering expression of genes managing protein folding. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts ER to Golgi transport, inducing ER stress and potentially affecting RFT1 expression as part of the unfolded protein response. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
An Hsp90 inhibitor that may induce the heat shock response, potentially affecting expression of chaperone genes and related proteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An inhibitor of the SERCA pump leading to calcium depletion in the ER and activation of the unfolded protein response, which may influence RFT1 expression. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $132.00 $529.00 $1005.00 $6125.00 | 25 | |
An inhibitor of mannosidase I in the ER, which may increase the need for proper N-linked glycosylation and affect RFT1 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Known to raise lysosomal pH, possibly impacting protein trafficking and cellular stress responses that could induce RFT1 expression. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $112.00 $199.00 $347.00 $683.00 $1336.00 $5722.00 | 12 | |
An inhibitor of ER-associated degradation, potentially increasing the burden on the ER and influencing the expression of genes like RFT1. | ||||||